Coya Therapeutics revenue was $423.45k for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $163.6k, down 36.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, COYA annual revenue was $3.6M, with -40.8% growth year-over-year.
COYA past revenue growth
How has COYA's revenue growth performed historically?
On Invalid Date, Coya Therapeutics (NASDAQ: COYA) reported Q2 2025 revenue of $163.62 thousand up 95.22% year over year. In the same quarter last year, Coya Therapeutics's revenue was $3.43 million.
What was Coya Therapeutics's revenue in 2024?
Coya Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $3.55 million, a 40.79% decrease year over year.
How much does Coya Therapeutics make in a day?
Based on Coya Therapeutics annual revenue for the past three years, COYA makes an average of $8,727.18 per day.
What was Coya Therapeutics's annual revenue growth in the past year?
As of Q3 2025, Coya Therapeutics's revenue has grown -95.57% year over year. This is 243.6 percentage points lower than the US Biotechnology industry revenue growth rate of 148.03%. Coya Therapeutics's revenue in the past year totaled $423.45 thousand.
How much does Coya Therapeutics make in a year?
Coya Therapeutics's revenue by year for the past three years is:
Coya Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $3.55 million, a 40.79% decrease year over year.
Coya Therapeutics's annual revenue for Dec 31, 2023 was $6.00 million, a Infinity% increase from 2022.
Coya Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.